Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Ethosomes can safely and effectively deliver various drugs deep into the skin.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

The document concludes that early diagnosis of Balint's syndrome is crucial for effective treatment and that understanding drug interactions, like between ritonavir and statins, is important for patient care.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Smaller nanoemulsions can penetrate skin and hair follicles better, which may be useful for delivering drugs and vaccines through the skin.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Folliculitis is an inflammation of hair follicles that requires proper diagnosis and treatment based on the specific cause.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Stopping isoniazid can reverse hair loss caused by the drug.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

Nanoemulsion-based drug delivery systems are versatile and have potential for treating various medical conditions and improving vaccines.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

The anti-viral drug Elvitegravir may protect brain cells from damage related to neurodegenerative diseases.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Clofazimine effectively treated a rare skin condition with ash-gray patches.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.